Strategic partnerships Opportunity to pursue collaborations with Bausch + Lomb in ophthalmic pharmaceuticals and eye health devices, leveraging their global reach and recent partnerships to co-develop or distribute innovative therapies and surgical solutions.

Growth momentum Strong revenue growth in Q1 2026 with year-over-year gains and scalable performance, signaling readiness to expand commercial partnerships, high-value product launches, and extended market penetration strategies.

Independent trajectory Bausch + Lomb is operating as a focused ophthalmic specialist with a broader spin-out history; potential buyers or partners can align with their emphasis on vision care products, contact lenses, and ophthalmic pharmaceuticals for targeted go-to-market programs.

Tech enabled Active use of modern tech stack and digital tools (Cloud, optimization, integration platforms, e-sign, and AI/chat enhancements) suggests openness to vendor solutions for CRM, data analytics, digital marketing, and workflow automation to improve sales and operations.

Leadership and continuity Recent leadership adjustments and board-level appointments indicate a stable, long-term strategy; sales opportunities can be positioned around strategic initiatives, channel expansion, and international market acceleration supported by executive sponsorship.